Results 91 to 100 of about 5,560 (153)

Human Substance P Interactions with G Protein-Coupled Receptor NK1R Observed by NMR in Solution. [PDF]

J Am Chem Soc
Ge H, Yang L, Chen C, Xu Y, Liu D, Wüthrich K.   +5 more
europepmc   +1 more source

Aprepitant and fosaprepitant as a prophylactic antiemetic for preventing postoperative nausea and vomiting after general anaesthesia: a systematic review and meta-analysis. [PDF]

Clinics (Sao Paulo)
Grigio TR, Timmerman H, Dos Santos NP, Pereira JEG, Sousa AM, Wolff AP.   +5 more
europepmc   +1 more source

Bidirectional substance P signaling between periodontal ligament fibroblasts and sensory neurons under mechanical stress. [PDF]

Front Mol Neurosci
Symmank J, Löffler L, Schulze-Späte U, Jacobs C.   +3 more
europepmc   +1 more source

Personalized Prophylactic Antiemetic Regimens for Control of Chemotherapy-Induced Nausea and Vomiting by Pharmacogenetic Analysis of Three Receptor Genes: HTR3A, HTR3B, TACR1. [PDF]

JCO Precis Oncol
Yeo W, Mo FKF, Huang J, Yeo HL, Ko WH, Li LV, Lau TKH, Lai KT, Pang E, Ou M, Ma SL, Tang NLS.   +11 more
europepmc   +1 more source

Efficacy of intensive antiemetic therapy including olanzapine in multiple myeloma patients treated with high-dose melphalan with autologous stem cell transplantation. [PDF]

Support Care Cancer
Kato J, Uchida M, Ishikawa M, Tatsuta S, Yoshimi T, Ishida K, Hosoya O, Tsukada N, Ishida T, Shiko Y, Kawasaki Y, Yamazaki S, Ishii I.   +12 more
europepmc   +1 more source

Trigeminal nerve-driven neurogenic inflammation linking migraine to glioblastoma invasion: a literature review. [PDF]

Front Immunol
Song X, Zhu Q, Zhang J, Yang J, Zhang X, Song Q.   +5 more
europepmc   +1 more source

Neuroendoscopy and Postoperative Nausea and Vomiting: Pathophysiology, Incidence and Management Strategies. [PDF]

Brain Sci
Pota V, Coletta F, Pascazio F, Rinaldi P, Tomasello A, De Marco GP, Schettino F, Passavanti MB, Sansone P, Pace MC, Barbarisi M, Altieri R, Villani R, Coppolino F.   +13 more
europepmc   +1 more source

PReCedeNT trial: Phase III randomized-controlled trial of Lutetium - 177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) plus Chemotherapy versus PRRT alone in FDG-avid, Well-differentiated Gastroenteropancreatic neuroendocrine tumors (GEP-NETs). [PDF]

BMC Cancer
Puranik AD, Dev ID, Yadav S, Rangarajan V, Agrawal A, Basu S, Chaudhari VA, Ramaswamy A, Ostwal V, Bhandare MS, Shrikhande SV, Parghane RV, Bhargava P, Bal MM, Yadav S, Patkar S, Goel M, Purandare NC, Shah S, Choudhury S, Ghosh S, Venkatachalam M.   +21 more
europepmc   +1 more source

Cyclic Vomiting Syndrome Versus Cannabinoid Hyperemesis Syndrome. [PDF]

J Neurogastroenterol Motil
Singh B, Grover P, Kaur G.
europepmc   +1 more source